RE:Too many things can go right at these price levels "Sale they made in panic"........LOL
What you write (and others.....) reads as a humorous narration!!!
Sellers didn't sell in panic, but in the knowledge the company did not deliver what was promised!!! It took way to long trough the fase 1 to see some efficacy and their "key" element that wasn't there....????!!!!. I won't write an essay anymore on all the things that went wrong (or at least not in the wright direction)....
And "At these price levels it qualifies as a stupid buy......" , stupid yes, thought out is another thing...!!!! Is the price really cheap for a company with no money, no partners, no insiders buying?????
Good luck with you're investment!!! (i am "in" other biotechs now, just a little TH left in one port. Will rebuy when insiders do.)
Trogarzon - (1/12/2023 9:22:47 AM)
Too many things can go right at these price levels
Given the many possible good surpises that can occur, may it be Nash combo partnership with Big Pharma given renewed interest in the Nash drugs or Trogarzo companion opportunity with Gilead new drug. Also any kind of life out of the Sort-1 platform will stir the soul of shareholders. Until then we have growing sales from legacy drugs and the sales structure is pretty decent now. At these price levels it qualifies as a stupid buy whatever the doom sayers will come up with to justify their frustrations or the sale they made in panic.